Case 329 #Neoleukin Therapeutics, Inc.
DISCLAIMER: The analysis is strictly for educational purposes and should not be construed as an invitation to trade.
#NLTX 1/4
NLTX 3/4
Daily Chart: The SMA 200 has been supporting the current up move since Aug. 2019. From Mar. 2020 trading has been confined to a triangle - but the base is unreliable and poses a risk.
The #Strategy is printed on the image.
$NLTX 4/4